Skip to content
healthcare.dev

Alendronate

NDC 10135-718, Alendronate sodium tablet, tablet, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-718
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090258
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-718 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALENDRONATE SODIUM35 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
10135-718-12101350718123 BLISTER PACK in 1 CARTON (10135-718-12) / 4 TABLET in 1 BLISTER PACK
10135-718-44101350718441 BLISTER PACK in 1 CARTON (10135-718-44) / 4 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b63421af-ec03-1de7-e053-2a95a90abec6

Use it

Look up 10135-718 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-718 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-718. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.